Objective Data regarding cardiovascular comorbidity and cardiovascular risk factors in
patients with psoriatic arthritis (PsA) are limited. To evaluate the cardiovascular risk profile, a …

Objective The aim of this study was to test the hypothesis that the reason for non-response (caused
by immunogenicity or not) to a first tumour necrosis factor (TNF) inhibitor defines …

Objective To investigate the relationship between serum etanercept levels and clinical
response. Methods In 292 etanercept-treated patients with rheumatoid arthritis clinical and …

Treatment with anti-tumour necrosis factor (TNF) is very effective in most patients with
ankylosing spondylitis (AS), but inefficacy occurs in about 40% of cases. 1 Antibody formation …

Objective To compare rates of sustained low and minimal disease activity and remission
according to the American College of Rheumatology/European League Against Rheumatism (…

Objective. Rheumatoid arthritis (RA) is characterized by high levels of cytokines such as
tumor necrosis factor (TNF). TNF appears to have an etiologic role in thyroid dysfunction, and …

Background The major risk factor for idiopathic pulmonary fibrosis (IPF), MUC5B rs35705950,
was found to be associated with rheumatoid arthritis-associated interstitial lung disease (…

Background Connective tissue diseases-associated interstitial lung disease (CTD-ILD) is a
heterogeneous condition that impairs quality of life and is associated with premature death. …

Objective. We investigated changes in high-density lipoprotein (HDL) profiling in patients with
rheumatoid arthritis who started treatment by taking tumor necrosis factor (TNF) inhibitors. …

SIR, In this report, a rare case of IgG4-related disease (IgG4-RD) in a patient presenting with
unilateral sacroiliitis and pulmonary lesions is described. This 70-year-old Caucasian male …